Literature DB >> 19456882

Acute myocardial infarction with sumatriptan: a case report and review of the literature.

Flavio Devetag Chalaupka1.   

Abstract

We report a case of myocardial infarction associated with the use of sumatriptan and review the literature regarding similar cases. A 54-year-old woman with a history of migraine without aura, mild arterial hypertension, depression, and no history of coronary artery disease was admitted to our hospital for acute myocardial infarction, 30 minutes after using 6 mg of subcutaneous sumatriptan. Coronary angiography performed several days later revealed a normal coronary arterial system. Although at discharge the patient was advised to permanently avoid triptans, she continued the use of oral sumatriptan at low dosage (25-50 mg) without any problems.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19456882     DOI: 10.1111/j.1526-4610.2009.01409.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  4 in total

1.  Using telcagepant for the acute treatment of migraine.

Authors:  Frederick R Taylor
Journal:  Curr Pain Headache Rep       Date:  2010-06

Review 2.  Metoclopramide for Acute Migraine Treatment in the Emergency Department: An Effective Alternative to Opioids.

Authors:  Mejdi Najjar; Tyler Hall; Blanca Estupinan
Journal:  Cureus       Date:  2017-04-20

3.  Pain reduction and adverse effects of intravenous metoclopramide for acute migraine attack: A systematic review and meta-analysis of randomized-controlled trials.

Authors:  Nat Ungrungseesopon; Wachira Wongtanasarasin
Journal:  World J Methodol       Date:  2022-07-20

4.  Triptans and vascular comorbidity in persons over fifty: Findings from a nationwide insurance database - A cohort study.

Authors:  Karin Zebenholzer; Walter Gall; Andreas Gleiss; Antun R Pavelic; Christian Wöber
Journal:  Headache       Date:  2022-05       Impact factor: 5.311

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.